Effects of omega‐3 supplementation on Ki‐67 and VEGF expression levels and clinical outcomes of locally advanced breast cancer patients treated with neoadjuvant CAF (cyclophosphamide, adriamycin, and fluorouracil) chemotherapy. This evidence concerns the gene MKI67 and breast carcinoma.